At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nonaromatic Naphthalan - Composition Study and Biological Effects on Epithelial Tissues
In Brief
A Phase 2 clinical trial evaluating NAVS Naphthalan and 0.05% Betamethasone dipropionate for Oral Lichen Planus and Recurrent Aphthous Stomatitis. Completed, enrolled 57 participants across 1 site.
Detailed Summary
This study evaluates the effectiveness of topical NAVS naphthalan in the treatment of oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS). Half of participants with OLP and RAS will receive topical NAVS naphthalan in adhesive paste, while the other half will receive 0.05%-betamethasone dipropionate in adhesive paste. Our hypothesis is that NAVS could be efficient in the treatment of OLP and RAS, with effects comparable to that of topical steroids.